These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15208677

  • 1. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE.
    Oncogene; 2004 Jul 29; 23(34):5834-42. PubMed ID: 15208677
    [Abstract] [Full Text] [Related]

  • 2. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE.
    Cancer Res; 2004 Jun 01; 64(11):3987-93. PubMed ID: 15173012
    [Abstract] [Full Text] [Related]

  • 3. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS, Ito H, Benoit E, Ashley SW, Whang EE.
    Br J Cancer; 2004 Oct 04; 91(7):1384-90. PubMed ID: 15316565
    [Abstract] [Full Text] [Related]

  • 4. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
    Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR.
    Cancer Res; 2001 Jan 15; 61(2):589-93. PubMed ID: 11212254
    [Abstract] [Full Text] [Related]

  • 5. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Oncogene; 2004 Jan 15; 23(2):465-73. PubMed ID: 14724575
    [Abstract] [Full Text] [Related]

  • 6. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
    Duxbury MS, Ito H, Ashley SW, Whang EE.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):133-41. PubMed ID: 15047158
    [Abstract] [Full Text] [Related]

  • 7. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Ashley SW, Whang EE.
    J Biol Chem; 2004 May 28; 279(22):23176-82. PubMed ID: 15047698
    [Abstract] [Full Text] [Related]

  • 8. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK, Kim SY, Hwang PH, Kim CY, Yang DH, Oh Y, Lee DY.
    Biochem Biophys Res Commun; 2005 May 13; 330(3):760-7. PubMed ID: 15809062
    [Abstract] [Full Text] [Related]

  • 9. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q, Liu B, Yan M.
    PLoS One; 2014 May 13; 9(11):e112908. PubMed ID: 25398131
    [Abstract] [Full Text] [Related]

  • 10. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D, Brodt P.
    Oncogene; 2003 Feb 20; 22(7):974-82. PubMed ID: 12592384
    [Abstract] [Full Text] [Related]

  • 11. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G, Wang D, Xiong F, Wang Q, Liu W, Chen J, Chen Y.
    Int J Oncol; 2024 Mar 20; 64(3):. PubMed ID: 38240103
    [Abstract] [Full Text] [Related]

  • 12. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 13. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
    Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Ann Surg; 2004 Oct 15; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
    [Abstract] [Full Text] [Related]

  • 14. Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression.
    Rizeq B, Zakaria Z, Ouhtit A.
    Cancer Sci; 2018 Jan 15; 109(1):33-42. PubMed ID: 29110374
    [Abstract] [Full Text] [Related]

  • 15. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
    Hermanto U, Zong CS, Li W, Wang LH.
    Mol Cell Biol; 2002 Apr 15; 22(7):2345-65. PubMed ID: 11884618
    [Abstract] [Full Text] [Related]

  • 16. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
    Duxbury MS, Ito H, Ashley SW, Whang EE.
    Biochem Biophys Res Commun; 2004 May 07; 317(3):837-43. PubMed ID: 15081416
    [Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
    Strickland LA, Ross J, Williams S, Ross S, Romero M, Spencer S, Erickson R, Sutcliffe J, Verbeke C, Polakis P, van Bruggen N, Koeppen H.
    J Pathol; 2009 Jul 07; 218(3):380-90. PubMed ID: 19334050
    [Abstract] [Full Text] [Related]

  • 18. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.
    Ganguly S, Basu B, Shome S, Jadhav T, Roy S, Majumdar J, Dasgupta PS, Basu S.
    Am J Pathol; 2010 Dec 07; 177(6):2701-7. PubMed ID: 21075859
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line.
    Kodama Y, Baxter RC, Martin JL.
    Am J Respir Cell Mol Biol; 2002 Sep 07; 27(3):336-44. PubMed ID: 12204896
    [Abstract] [Full Text] [Related]

  • 20. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.
    Kulik G, Klippel A, Weber MJ.
    Mol Cell Biol; 1997 Mar 07; 17(3):1595-606. PubMed ID: 9032287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.